Virology News
59.0K views | +59 today
Follow
 
Scooped by Ed Rybicki
onto Virology News
Scoop.it!

'Guilty pleasures' can get us through social distancing

'Guilty pleasures' can get us through social distancing | Virology News | Scoop.it
Social distancing protects us from COVID-19. But how can we protect our mental health as we're isolating? One solution: Indulge in guilty pleasures.
No comment yet.
Virology News
Topical news snippets about viruses that affect people.  And other things. Like Led Zeppelin. And zombies B-)
Curated by Ed Rybicki
Your new post is loading...
Your new post is loading...
Scooped by Ed Rybicki
Scoop.it!

Why the Covid-19 coronavirus is worse than the flu, in one chart

Why the Covid-19 coronavirus is worse than the flu, in one chart | Virology News | Scoop.it
It’s more contagious, more deadly (particularly for older people), and it has a greater potential to overwhelm our health care system.
Ed Rybicki's insight:
GREAT graphic!!
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

COVID-19's economic effects could last decades

COVID-19's economic effects could last decades | Virology News | Scoop.it
A look back at the economic effect of past pandemics shows that we could be facing COVID-19's impact for years and years to come.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

The influenza pandemic of 1918–1919 in Sri Lanka: its demographic cost, timing, and propagation

The influenza pandemic of 1918–1919 in Sri Lanka: its demographic cost, timing, and propagation | Virology News | Scoop.it
As an island and a former British colony, Sri Lanka is a case of special interest for the study of 1918–1919 influenza pandemic because of its potential for isolation from as well as integration into the world epidemiologic system.To estimate ...
Ed Rybicki's insight:
100 years on, still lessons to be learned
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Some people who recover from the coronavirus might be left with '20 to 30%' less lung function, and gasping for breath when they walk quickly, Hong Kong doctors said

Some people who recover from the coronavirus might be left with '20 to 30%' less lung function, and gasping for breath when they walk quickly, Hong Kong doctors said | Virology News | Scoop.it
The Hong Kong Hospital Authority made the discovery after observing the first wave of discharged patients in the city.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Bill Lapschies, Survivor of Spanish Flu, Recovers From Coronavirus

Bill Lapschies, Survivor of Spanish Flu, Recovers From Coronavirus | Virology News | Scoop.it
World War II vet Bill Lapschies was feted on his 104th birthday Wednesday, also celebrating his recovery from the coronavirus.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Coronavirus Australia: $230 million boost for CSIRO's COVID vaccine push

Coronavirus Australia: $230 million boost for CSIRO's COVID vaccine push | Virology News | Scoop.it
Government will spend $220m to upgrade the Geelong lab currently testing two vaccines for COVID-19, Science Minister Karen Andrews will announce Saturday.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Ferrets, hamsters will soon reveal whether Canadian vaccine bid has a shot

Ferrets, hamsters will soon reveal whether Canadian vaccine bid has a shot | Virology News | Scoop.it
Saskatchewan lab finding ways to fast-track research amid COVID-19 pandemic...
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Coronavirus: Anti-Parasite Drug Ivermectin Kills Coronavirus Within 48 Hours In Lab Settings, Claims Report

Coronavirus: Anti-Parasite Drug Ivermectin Kills Coronavirus Within 48 Hours In Lab Settings, Claims Report | Virology News | Scoop.it
Amid a barrage of research on finding treatment for new coronavirus, Australian scientists have found that a common anti-parasitic drug killed SARS-CoV-2 virus, growing in cell culture, within 48 hours in lab settings. Ivermectin is an FDA-approved anti-parasitic drug that has also been shown to be effective in vitro against a broad range of viruses including HIV, dengue, influenza and zika virus. Published in the journal Antiviral Research, the study from Monash University showed that a single dose of Ivermectin could stop the coronavirus growing in cell culture -- effectively eradicating all genetic material of the virus within two days. "We found that even a single dose could essentially remove all viral RNA by 48 hours and that even at 24 hours there was a really significant reduction in it," said study lead author Dr Kylie Wagstaff. Dr Wagstaff, however, cautioned that the tests conducted in the study were in vitro and that trials needed to be carried out in people. "Ivermectin is very widely used and seen as a safe drug. We need to figure out now whether the dosage you can use it at in humans will be effective - that''s the next step," Wagstaff informed. In times when we're having a global pandemic and there isn't an approved treatment, "if we had a compound that was already available around the world then that might help people sooner". "Realistically it's going to be a while before a vaccine is broadly available," she said. Although the mechanism by which Ivermectin works on the virus is not known, it is likely, based on its action in other viruses, that it works to stop the virus ''dampening down'' the host cells' ability to clear it. Dr Wagstaff made a previous breakthrough finding on Ivermectin in 2012 when she identified the drug and its antiviral activity with Monash Biomedicine Discovery Institute's Professor David Jans, also an author on this paper. Professor Jans and his team have been researching Ivermectin for more than 10 years with different viruses. Dr Wagstaff and Professor Jans started investigating whether it worked on the SARS-CoV-2 virus as soon as the pandemic was known to have started. The use of Ivermectin to combat COVID-19 depends on pre-clinical testing and clinical trials, with funding urgently required to progress the work, the researchers noted. (This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.)
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Team tracks coronavirus in wastewater

Team tracks coronavirus in wastewater | Virology News | Scoop.it
Testing for the new coronavirus in wastewater to trace its prevalence in US communities could help public health officials better prepare for the future.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

See Bill Gates’ Chilling Pandemic Warnings To Trump – Before The Coronavirus Outbreak Hit 

No comment yet.
Scooped by Ed Rybicki
Scoop.it!

COVID-19 precautions are impossible in prisons

COVID-19 precautions are impossible in prisons | Virology News | Scoop.it
"A prison in a pandemic becomes akin to a cruise ship—people are crowded into a shared space that they cannot leave." Here are prisons' COVID-19 options.
Ed Rybicki's insight:
We have a large and very crowded prison population in South Africa. It could get really bad here.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Coronavirus: Saskatoon lab tests potential vaccine on ferrets

Coronavirus: Saskatoon lab tests potential vaccine on ferrets | Virology News | Scoop.it
VIDO-InterVac said it has isolated the coronavirus in its lab and generated a vaccine that it's now testing on ferrets.
Ed Rybicki's comment, April 2, 5:53 AM
No indication of what the vaccine is!!
Scooped by Ed Rybicki
Scoop.it!

This is no April Fool's. British American Tobacco is trying to make a coronavirus vaccine

This is no April Fool's. British American Tobacco is trying to make a coronavirus vaccine | Virology News | Scoop.it
The maker of Camel, Lucky Strike and Pall Mall cigarettes is trying its hand at a new product: a coronavirus vaccine.
Ed Rybicki's insight:
Sigh...they say BAT, and then they show KBP's sign! They were making drugs / candidate vaccines in plants LONG before BAT  / RJ Reynolds bought them.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Avigan influenza antiviral to enter phase III trials in COVID-19 patients

Avigan influenza antiviral to enter phase III trials in COVID-19 patients | Virology News | Scoop.it
The developers of Avigan have increased production and announced a Phase III clinical trial testing its efficacy against COVID-19.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Coronavirus vaccine patch shows promise in mice

Coronavirus vaccine patch shows promise in mice | Virology News | Scoop.it
Scientists have now published the first peer-reviewed study on a potential vaccine against SARS-CoV-2. They've tested the microneedle array on mice.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Inovio Pharmaceuticals, Inc. (INO): A potential coronavirus vaccine funded by Bill Gates

Inovio Pharmaceuticals, Inc. (INO): A potential coronavirus vaccine funded by Bill Gates | Virology News | Scoop.it
Inovio Pharmaceuticals, Inc.INO Stock Message Board: A potential coronavirus vaccine funded by Bill Gates...
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Oldest human genetic data may expand our 'family tree'

Oldest human genetic data may expand our 'family tree' | Virology News | Scoop.it
The oldest human genetic data ever recovered could shed light on the evolution of our ancestors and clarify the branches of the human family tree.
Ed Rybicki's insight:
Hey, It's not ALL about SARS2!
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

At the frontlines of Nigeria’s COVID-19 response

At the frontlines of Nigeria’s COVID-19 response | Virology News | Scoop.it
Ultra-low freezers hum and beep continuously in the biorespository room, supporting the non-stop diagnostic activities at the National Public Health Reference Laboratory in Gaduwa, Abuja, on a relatively quiet Friday afternoon.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

COVID-19's economic effects could last decades

COVID-19's economic effects could last decades | Virology News | Scoop.it
A look back at the economic effect of past pandemics shows that we could be facing COVID-19's impact for years and years to come.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

US flu activity drops sharply; death toll holds at 24K

US flu activity drops sharply; death toll holds at 24K | Virology News | Scoop.it
While the U.S. flu season is ebbing, it’s still not over.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Anthony Fauci says it's likely coronavirus will become 'seasonal'

Anthony Fauci says it's likely coronavirus will become 'seasonal' | Virology News | Scoop.it
Dr. Anthony Fauci, an infectious disease expert on the White House task force, said Sunday it is likely that coronavirus will become a seasonal illness.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Presymptomatic Transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020

Presymptomatic Transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020 | Virology News | Scoop.it
Investigation of all 243 cases of COVID-19 reported in Singapore during January 23–March 16 identified seven clusters of cases in which presymptomatic transmission is the most likely explanation for the occurrence of secondary cases.
Ed Rybicki's insight:
Share your insight
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Novel coronavirus vaccine being tested on rodents in Israel 

Novel coronavirus vaccine being tested on rodents in Israel  | Virology News | Scoop.it
The institute's director told Prime Minister Benjamin Netanyahu that the vaccine was being readied for testing in animals.
Ed Rybicki's insight:
Share your insight
Ed Rybicki's comment, April 2, 5:53 AM
And yet again, they don't say what it is B-(
Scooped by Ed Rybicki
Scoop.it!

Researchers team up to design face shield kits

Researchers team up to design face shield kits | Virology News | Scoop.it
"These face shields are a key component of the equipment that helps keep our providers safe while caring for patients during this critical time."...
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Australia begins pre-clinical testing for virus vaccine

Australia begins pre-clinical testing for virus vaccine | Virology News | Scoop.it
Australia's national science agency has said that it has commenced the first stage of testing potential vaccines for Covid-19, as it joins a global race to halt the coronavirus pandemic.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

A Simplified Method to Engineer CRISPR/Cas9-Mediated Geminivirus Resistance in Plants

It's not all about COVID B-)I

No comment yet.